Description:
GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Carbohydrate Metabolism |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
4 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
| |
| GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
| |
| Remarks |
Normal debrancher enzyme activity in fibroblasts |
| dbSNP |
dbSNP ID: 10432 |
| Gene Ontology |
GO:0004689 phosphorylase kinase activity |
|
GO:0005516 calmodulin binding |
|
GO:0005964 phosphorylase kinase complex |
|
GO:0005975 carbohydrate metabolism |
|
GO:0005977 glycogen metabolism |
|
GO:0006091 energy pathways |
|
GO:0006464 protein modification |
| NCBI Gene |
Gene ID:5256 |
| NCBI GTR |
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1 |
| OMIM |
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1 |
| Omim Description |
GLYCOGEN STORAGE DISEASE IX, INCLUDED |
| |
GLYCOGEN STORAGE DISEASE VIII |
| |
GLYCOGENOSIS VIIIA |
| |
HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK |
| |
LIVER GLYCOGENOSIS, X-LINKED, TYPE I |
| |
LIVER GLYCOGENOSIS, X-LINKED, TYPE II, INCLUDED; XLG2, INCLUDED |
| |
PHKA, INCLUDED |
| |
PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL |
| |
X-LINKED LIVER GLYCOGENOSIS; XLGPHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT, INCLUDED; PHKA2, INCLUDED |
| Passage Frozen |
4 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|